These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 21622972)

  • 1. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents.
    Desbois AP; Coote PJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1785-90. PubMed ID: 21622972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic epidermicin NI01 can protect Galleria mellonella larvae from infection with Staphylococcus aureus.
    Gibreel TM; Upton M
    J Antimicrob Chemother; 2013 Oct; 68(10):2269-73. PubMed ID: 23711896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS; Shin WS; Kim SK
    J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
    Hill L; Veli N; Coote PJ
    Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New agents for Staphylococcus aureus endocarditis.
    Drees M; Boucher H
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Jacqueline C; Amador G; Batard E; Le Mabecque V; Miègeville AF; Biek D; Caillon J; Potel G
    J Antimicrob Chemother; 2011 Apr; 66(4):863-6. PubMed ID: 21393213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus.
    Reyes N; Skinner R; Benton BM; Krause KM; Shelton J; Obedencio GP; Hegde SS
    J Antimicrob Chemother; 2006 Aug; 58(2):462-5. PubMed ID: 16735425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis.
    Velikova N; Kavanagh K; Wells JM
    BMC Microbiol; 2016 Dec; 16(1):291. PubMed ID: 27978817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenylated flavonoid-enriched fraction from Maclura tinctoria shows biological activity against Staphylococcus aureus and protects Galleria mellonella larvae from bacterial infection.
    das Chagas Almeida A; Azevedo Rodrigues L; Dos Santos Paulino G; Pereira Aguilar A; Andrade Almeida A; Olavo Ferreira S; Brandão GC; Viana Leite JP; de Oliveira Barros Ribon A
    BMC Complement Altern Med; 2019 Jul; 19(1):189. PubMed ID: 31357964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments.
    Entwistle FM; Coote PJ
    J Med Microbiol; 2018 Apr; 67(4):585-597. PubMed ID: 29458557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
    Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.